Molecular Biology of the Cell click for ASCB 2009 Annual Meeting page

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E03-10-0753 on May 14, 2004

Vol. 15, Issue 7, 3464-3474, July 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E03-10-0753v1
15/7/3464    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bennasroune, A.
Right arrow Articles by Hubert, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bennasroune, A.
Right arrow Articles by Hubert, P.

Transmembrane Peptides as Inhibitors of ErbB Receptor Signaling

Amar Bennasroune *, Maria Fickova {dagger}, Anne Gardin * {ddagger}, Sylvie Dirrig-Grosch *, Dominique Aunis *, Gérard Crémel *, and Pierre Hubert * §

* Institut National de la Santé et de la Recherche Médicale Unit 575, and Université Louis Pasteur, 67084 Strasbourg, France; {dagger} Institute of Experimental Endocrinology, Slovak Academy of Sciences, 833 06 Bratislava, Slovak Republic

Submitted October 22, 2003; Revised April 23, 2004; Accepted May 3, 2004
Monitoring Editor: Guido Guidotti

Receptor tyrosine kinases have a single transmembrane (TM) segment that is usually assumed to play a passive role in ligand-induced dimerization and activation of the receptor. However, mutations within some of these receptors, and recent studies with the epidermal growth factor (EGF) and ErbB2 receptors have indicated that interactions between TM domains do contribute to stabilization of ligand-independent and/or ligand-induced receptor dimerization and activation. One consequence of the importance of these interactions is that short hydrophobic peptides corresponding to these domains should act as specific inhibitors. To test this hypothesis, we constructed expression vectors encoding short fusion peptides encompassing native or mutated TM domains of the EGF, ErbB2, and insulin receptors. In human cell lines overexpressing the wild-type EGF receptor or ErbB2, we observed that the peptides are expressed at the cell surface and that they inhibit specifically the autophosphorylation and signaling pathway of their cognate receptor. Identical results were obtained with peptides chemically synthesized. Mechanism of action involves inhibition of dimerization of the receptors as shown by the lack of effects of mutant nondimerizing sequences, completed by density centrifugation and covalent cross-linking experiments. Our findings stress the role of TM domain interactions in ErbB receptor function, and possibly for other single-spanning membrane proteins.


Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.E03-10-0753. Article and publication date are available at www.molbiolcell.org/cgi/doi/10.1091/mbc.E03-10-0753.

Abbreviations used: EGF(R), epidermal growth factor (receptor); ET, extracellular tag; RTK, receptor tyrosine kinase; TM, transmembrane.

{ddagger} Present address: Novartis Pharma AG, Clinical Pharmacology Department, Lichtstrasse 35, CH-4056 Basel, Switzerland.

§ Corresponding author. E-mail address: hubert{at}neurochem.u-strasbg.fr.




This article has been cited by other articles:


Home page
Plant CellHome page
R. Muller, A. Bleckmann, and R. Simon
The Receptor Kinase CORYNE of Arabidopsis Transmits the Stem Cell-Limiting Signal CLAVATA3 Independently of CLAVATA1
PLANT CELL, April 1, 2008; 20(4): 934 - 946.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. V. Bocharov, K. S. Mineev, P. E. Volynsky, Y. S. Ermolyuk, E. N. Tkach, A. G. Sobol, V. V. Chupin, M. P. Kirpichnikov, R. G. Efremov, and A. S. Arseniev
Spatial Structure of the Dimeric Transmembrane Domain of the Growth Factor Receptor ErbB2 Presumably Corresponding to the Receptor Active State
J. Biol. Chem., March 14, 2008; 283(11): 6950 - 6956.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
L. Roth, C. Nasarre, S. Dirrig-Grosch, D. Aunis, G. Cremel, P. Hubert, and D. Bagnard
Transmembrane Domain Interactions Control Biological Functions of Neuropilin-1
Mol. Biol. Cell, February 1, 2008; 19(2): 646 - 654.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. W. B. de Groot, T. P. Links, J. T. M. Plukker, C. J. M. Lips, and R. M. W. Hofstra
RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors
Endocr. Rev., August 1, 2006; 27(5): 535 - 560.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. T. Marchesi
An alternative interpretation of the amyloid A{beta} hypothesis with regard to the pathogenesis of Alzheimer's disease
PNAS, June 28, 2005; 102(26): 9093 - 9098.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
L. K. Fritz-Laylin, N. Krishnamurthy, M. Tor, K. V. Sjolander, and J. D.G. Jones
Phylogenomic Analysis of the Receptor-Like Proteins of Rice and Arabidopsis
Plant Physiology, June 1, 2005; 138(2): 611 - 623.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2004 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.